Handelnine Global LLC Recalls Rheumacare Capsules Due to Lead Contamination
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Handelnine Global LLC has issued a voluntary recall for Rheumacare capsules after testing revealed the presence of lead, posing a serious health risk.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references New York. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
Handelnine Global LLC, based in South Plainfield, New Jersey, has initiated a voluntary recall of Rheumacare capsules. The recall was triggered by Current Good Manufacturing Practice (CGMP) deviations after the product was found to contain lead. The FDA has classified this as a Class I recall, the most serious category of recall.
Which Products Are Affected
The recall involves Rheumacare capsules packaged in 30-count bottles. The product was manufactured in India by Virgo UAP Pharma Pvt. Ltd. and distributed to a single customer in New York.
Product Details:
- Product Name: Rheumacare capsules
- UPC: 8 904218 700313
- Lot Numbers:
- Lot: CAM040 (Expiration: 06/30/2029)
- Lot: CAL079-N (Expiration: 09/30/2028)
- Quantity: 4 bottles
- Recall Number: D-0332-2026
What You Should Do
Consumers who have purchased the affected Rheumacare capsules should stop using the product immediately. The recalling firm, Handelnine Global LLC, is located at 4300 S Clinton Ave, South Plainfield, NJ 07080. While the distribution was limited to one customer in New York, anyone with these specific lot numbers should follow the instructions provided in the firm's press release regarding returns or disposal.
Why This Matters
This recall is significant due to the presence of lead, a heavy metal that can cause serious health issues and toxicity. A Class I classification indicates that there is a reasonable probability that the use of or exposure to the product will cause serious adverse health consequences or death.
Source
Information provided by the FDA under recall event ID 98165.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.